United States · FDA National Drug Code directory

SEROQUEL XR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 61269-272_30d64c02-e070-43b8-9c96-3f7b112c5f7c
Product NDC: 61269-272
Form: TABLET, EXTENDED RELEASE
Composition / generic term: quetiapine
Labeler: H2-Pharma, LLC
Marketing category: NDA
Marketing start / end (source format): 20070716
Source listing expiry: 20271231

Source-listed ingredients

QUETIAPINE FUMARATE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-272-60) · 61269-272-60

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →